Publications:

*CAPILLARY ELECTROPHORESIS IN CLINICAL CHEMISTRY, Y. Xu¿ in Encyclopedia of Analytical Chemistry: Instrumentation and Applications, Ed. Meyers, R. A.  John Wiley & Sons Ltd., 2000; pp. 1181-1199

*SIMULTANEOUS DETERMINATION OF ENANTIOMERS OF STRUCTURALLY RELATED ANTICHOLINERGIC ANALOGS IN HUMAN SERUM BY LC/ESI-MS WITH ON-LINE SAMPLE CLEANUP, V. Capka, Y. Xu#, Journal of Chromatography B 762, 181-192 (2001)

*RAPID DETERMINATION OF MELATONIN IN HUMAN SERUM BY ESI-MS-MS WITH ON-LINE SAMPLE EXTRACTION, S. Yang, X. Zheng, Y. Xu#, X. Zhou, Journal of Pharmaceutical and Biomedical Analysis 30, 781-790 (2002)

*LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY METHOD FOR THE ANALYSIS OF THE ANTI-CANCER AGENT CAPECITABINE AND ITS NUCLEOSIDE METABOLITES IN HUMAN PLASMA, Y. Xu, J. L. Grem#, Journal of Chromatography B 783, 273-285 (2003)

*MEASUREMENT OF ANTI-CANCER AGENT METHOXYAMINE IN PLASMA BY TANDEM MASS SPECTROMETRY WITH ON-LINE SAMPLE EXTRACTION, S. Yang, L. Liu, S. L. Gerson, Y. Xu#,  Journal of Chromatography B 795, 295-307 (2003)

*DETERMINATION OF GENISTEIN AND DAIDZEIN IN HUMAN PLASMA BY LIQUID CHROMATOGRAPHY AND TANDEM MASS SPECTROMETRY, S. Yang, X. Zhou, Y. Xu#,   Journal of Liquid Chromatography and Related Technologies 27, 471-489 (2004)

*MEASUREMENT OF THE ANTICANCER AGENT GEMCITABINE AND ITS DEAMINATED METABOLITE AT LOW CONCENTRATIONS IN HUMAN PLASMA BY LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRIC DETECTION, Y. Xu#, B. Keith, J. L. Grem, Journal of Chromatography B 802, 263-270 (2004)

*DEVELOPMENT AND VALIDATION OF AN HPLC-UV METHOD FOR THE ANALYSIS OF METHOXYAMINE USING 4-(DIETHYLAMINO)BENZALDEHYDE AS A DERIVATIZING AGENT, Y.C. Liao, S. Yang, M.J. Syu, Y. Xu#, Journal of Pharmaceutical and Biomedical Analysis 39, 724-729 (2005).

*DETERMINATION OF ENDOCANNABINOID RECEPTOR ANTAGONIST SR141716 (RIMONABANT) IN PLASMA BY LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY, M. McCulloch, X. Zhou, Yan Xu#, S. Brunell, L. Spear, Journal of Chromatography B, 863, 258¿265 (2008).

*DETERMINATION OF 6-BENZYLTHIOINOSINE IN MOUSE AND HUMAN PLASMA BY LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY, L. Li, Y. Xu#, D.N. Wald, W. Tse, Journal of Chromatography B, 877, 3871-3877 (2009).

*TARGETING BASE EXCISION REPAIR SUGGESTS A NEW THERAPEUTIC STRATEGY OF FLUDARABINE FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA.  A.D. Bulgar, M. Snell, J.R. Donze, E.B. Kirkland, L. Li, S. Yang, Y. Xu, S.L. Gerson, L. Liu#, Leukemia, 24, 1795-1799 (2010).

*DNMT1 STABILITY IS REGULATED BY PROTEINS COORDINATING DEUBIQUITINATION AND ACETYLATION-DRIVEN UBIQUITINATION, Z. Du, J. Song, Y. Wang, Y. Zhao, K. Guda, S. Yang, H.Y. Kao, Y. Xu, J. Willis, S.D. Markowitz, D. Sedwick, R.M. Ewing, Z. Wang#, Science Signaling, 3, 146 ra80 (2010).

*QUANTIFICATION OF HEXAMETHYLENE BISACETAMIDE, AN ANTINEOPLASTIC COMPOUND, IN MOUSE AND HUMAN PLASMA BY LC-MS/MS. K.M. Smith, W. Kechrt, X. Zhou, M.M. Montano, Y. Xu#, Journal of Chromatography B, 879: 2206-2212 (2011).

*DESIGN AND SYNTHESIS OF A BIOTINYLATED PROBE OF COX-2 INHIBITOR NIMESULIDE ANALOG JCC76.  B. Zhong, R. Lama, K. Smith, Y. Xu, B. Su#, Biorganic & Medicinal Chemistry Letters, 21: 5324-5327 (2011).

*FROM COX-2 INHIBITOR NIMESULIDE TO POTENT ANTI-CANCER AGENT: SYNTHESIS, IN VITRO, IN VIVO AND PHARMACOKINETIC EVALUATION.  B. Zhong, X. Cai, S. Chennamaneni, X. Yi, L. Liu, J. Pink, A. Dowlati, Y. Xu, A. Zhou, B. Su#, European Journal of Medicinal Chemistry, 47: 432-444 (2012).

*REMOVAL OF URACIL BY URACIL DNA GLYCOSYLASE LIMITS PEMETREXED CYTOTOXICITY: OVERRIDING THE LIMIT WITH METHOXYAMINE TO INHIBIT BASE EXCISION REPAIR.  A.D. Bulgar, L.D. Weeks, Y. Miao, S. Yang, Y. Xu, C. Guo, Markowitz, N. Oleinick, S.L. Gerson, L. Liu#, Cell Death and Disease, 3, e252; doi: 10.1038/cddis.2011.135 (2012).

*TISSUE SAMPLE PREPARATION IN BIOANALYTICAL ASSAYS - A REVIEW.  K.M. Smith, Y. Xu, Bioanalysis, 4: 741-749 (2012).

*IDENTIFICATION OF A CLASS OF NOVEL TUBULIN INHIBITORS.  X. Yi, B. Zhonga, K.M. Smith, W.J. Geldenhuys, Y. Feng, J.J. Pink, A. Dowlatie, Y. Xu, A. Zhou, B. Su#,  Journal of Medicinal Chemistry, 55: 3425-3435 (2012).

*DEVELOPMENT AND VALIDATION OF AN LC-MS/MS METHOD FOR PHARMACOKINETIC STUDY OF METHOXYAMINE IN PHASE I CLINICAL TRIAL.  S. Yang, P. Savvides, L. Liu, S.L. Gerson, Y. Xu#,  Journal of Chromatography B, 901; 25-33 (2012).

* UNDERSTANDING THE MOLECULAR DETERMINANTS OF SUBSTRATE AND INHIBITOR SPECIFICITY IN THE CARBAPENEMASE, KPC-2: EXPLORING THE ROLES OF ARG220 AND GLU276.  K. Papp-Wallace, M. Taracila, K. Smith, Y. Xu, R. Bonomo#,  Antimicrobial Agents and Chemotherapy, 56: 4428-4438 (2012).

*EXPLORING THE ROLE OF A CONSERVED CLASS A RESIDUE IN THE ¿-LOOP OF KPC-2 ß-LACTAMASE: A MECHANISM FOR CEFTAZIDIME HYDROLYSIS.  P.S. Levitt, K.M. Papp-Wallace, M.A. Taracila, A.M. Hujer, M.L. Winkler, K.M. Smith, Y. Xu, M.E. Harris, R.A. Bonomo#, Journal of Biological Chemistry, 287; 31783-31793 (2012).

*A PHASE 1 STUDY OF TRC102, AN INHIBITOR OF BASE EXCISION REPAIR, AND PEMETREXED IN PATIENTS WITH ADVANCED SOLID TUMORS.  M.S. Gordon#, L.S. Rosen, D. Mendelson, R.K. Ramanathan, J. Goldman, L. Liu, Y. Xu, S.L. Gerson, S.P. Anthony, W.D. Figg, S. Spencer, B.J. Adams, C.P. Theuer, B.R. Leigh, G.J. Weiss, Investigational New Drugs, DOI: 10.1007/s10637-012-9876-9 (2012).

**CAPILLARY ELECTROPHORESIS IN CLINICAL CHEMISTRY.  S.L. Wabuyele, Y. Xu#, in Encyclopedia of Analytical Chemistry, Ed. R.A. Meyers, John Wiley: Chichester, DOI: 10.1002/9780470027318.a0506.pub2 (2012)

*DESIGN AND EXPLORATION OF NOVEL BORONIC ACID INHIBITORS REVEALS IMPORTANT INTERACTIONS WITH A CLAVULANIC ACID-RESISTANT SULFHYDRYL-VARIABLE (SHV) ß-LACTAMASE.  M.L. Winkler, E.A. Rodkey, M.A. Taracila, S.M. Drawz, C.R. Bethel, K.M. Papp-Wallace, K.M. Smith, Y. Xu, J.R Dwulit-Smith, C. Romagnoli, E. Caselli, F. Prati, F. van den Akker, R.A. Bonomo#, Journal of Medicinal Chemistry, DOI: 10.1021/jm301490d (2012)

*INHIBITION OF METASTASIS BY HEXIM1 THROUGH EFFECTS ON CELL INVASION AND ANGIOGENESIS.  W. Ketchart, K.M. Smith, T. Krupka, B. Wittmann, Y. Hu, P.A. Rayman, Y. Q. Dougman, J.M. Albert, X. Bai, J.H. Finke, Y. Xu, A.A. Exner, M.M. Montano#, Oncogene, doi:10.1038/onc.2012.405 (2012)

*SYNTHESIS AND ANTI-CANCER MECHANISM INVESTIGATION OF DUAL HSP27 AND TUBULIN BINDERS.  B. Su#, B. Zhong, S. Chennamaneni, R. Lama, X. Yi, W. Geldenhuys, J. Pink, A. Dowlati, Y. Xu, A. Zhou, Journal of Medicinal Chemistry, 56, 5306-5320 (2013)  

*VOLTAGE-CONTROLLED ENZYME-CATALYZED GLUCOSE-GLUCONOLACTONE CONVERSION USING A FIELD-EFFECT ENZYMATIC DETECTOR.  S.-T. Yau#, Y. Xu, Y. Song, Y. Feng, J Wang, Physical Chemistry Chemical Physics, 15:  20134-20139 (2013)

*CAN INHIBITOR RESISTANT SUBSTITUTIONS IN THE MYCOBACTERIUM TUBERCULOSIS ß-LACTAMASE BLAC LEAD TO CLAVULANATE RESISTANCE? A BIOCHEMICAL RATIONALE FOR THE USE OF ß-LACTAM ß-LACTAMASE INHIBITOR COMBINATIONS.  S.G. Kurz, K.A. Wolff, S. Hazra, C.R. Bethel, A.M. Hujer, K.M. Smith, Y. Xu, L.W. Tremblay, J.S. Blanchard, L. Nguyen, R.A. Bonomo#, Antimicrobial Agents and Chemotherapy, 57; 6085-6096 (2013)

*DEVELOPMENT AND CHARACTERIZATION OF A NON-NATURAL NUCLEOSIDE THAT DISPLAYS ANTI-CANCER ACTIVITY AGAINST SOLID TUMORS.  J. Golden, E. Motea, X. Zhang, J.-S. Choi, Y. Feng, Y. Xu, I. Lee, A. Berdis#,   ACS Chemical Biology, 8, 2452-2465 (2013)

*DESIGN AND EXPLORATION OF NOVEL BORONIC ACID INHIBITORS REVEALS IMPORTANT INTERACTIONS WITH A CLAVULANIC ACID-RESISTANT SULFHYDRYL-VARIABLE (SHV) ß-LACTAMASE.  M.L. Winkler, E.A. Rodkey, M.A. Taracila, S.M. Drawz, C.R. Bethel, K.M. Papp-Wallace, K.M. Smith, Y. Xu, J.R. Dwulit-Smith, C. Romagnoli, E. Caselli, F. Prati, F. van den Akker, R.A. Bonomo#, Journal of Medicinal Chemistry, 56, 1084-1097 (2013).

*ß-LACTAMASE INHIBITION BY 7-ALKYLIDENECEPHALOSPORIN SULFONES: ALLYLIC TRANSPOSITION AND FORMATION OF AN UNPRECEDENTED STABILIZED ACYL-ENZYME.  E. Rodkey, D. McLeod, C. Bethel, K. Smith, Y. Xu, W. Chai, T. Che, P. Carey, R. Bonomo, F. van den Akker, J. Buynak#, Journal of the American Chemical Society, 135, 18358-18369 (2013).

*DEVELOPMENT OF A LIQUID CHROMATOGRAPHIC METHOD FOR QUANTITATIVE DETERMINATION OF TRIAPINE, A RIBONUCLEOTIDE REDUCTASE INHIBITOR, BY SPECTROPHOTOMETRIC STUDY OF TRIAPINE COMPLEXATION REACTION.  Y. Feng, M. McCulloch, Y. Xu#, Journal of Liquid Chromatography and Related Technologies, 37, 1351-1372 (2014).

*A KINETIC ANALYSIS OF THE INHIBITION OF FOX-4 ß-LACTAMASE, A PLASMID MEDIATED AMPC CEPHALOSPORINASE, BY MONOCYCLIC ß-LACTAMS AND CARBAPENEMS.  K. Papp-Wallace, S. Mallo, C. Bethel, M. Taracila, A. Hujer, A. Fernandez, J. Gatta, K. Smith, Y. Xu, M. Page, E. Desarbre, G. Bou, R. Bonomo#, Journal of Antimicrobial Chemotherapy, 69, 682-690 (2014).

*DEVELOPMENT AND VALIDATION OF LC-MS-MS METHOD FOR QUANTITATIVE DETERMINATION OF SECURININE IN MOUSE PLASMA.  S. Wabuyele, D. Wald, Y. Xu#, Journal of Chromatography B, 960, 19¿26 (2014).

*MEDIATORLESS IMMUNOASSAY WITH VOLTAGE-CONTROLLED INTRINSIC AMPLIFICATION FOR ULTRASENSITIVE AND RAPID DETECTION OF MICROORGANISM PATHOGENS.  J. Wang, Y. Xu, S.-T. Yau#, ChemElectroChem, 1, 741-746 (2014).

*RECLAIMING THE EFFICACY OF ß-LACTAM-ß-LACTAMASE INHIBITOR COMBINATIONS: AVIBACTAM RESTORES THE SUSCEPTIBILITY OF CEFTAZIDIME AGAINST CMY-2 PRODUCING ESCHERICHIA COLI.  Krisztina Papp-Wallace, Marisa Winkler, Julian Gatta, Magdalena Taracila, Sujatha Chilakala, Yan Xu, J. Johnson, Robert Bonomo, Antimicrobial Agents and Chemotherapy, DOI:10.1128/AAC.02625-14 (May 2014).

*CHAPTER 33: DETERMINATION OF TRICYCLIC ANTIDEPRESSANTS IN HUMAN BIOLOGICAL SAMPLES BY LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRY.  Shuming Yang and Yan Xu, in Applications of Liquid Chromatography-Mass Spectrometry in Clinical Laboratories, Eds.  Shuijun Li and Sihe Wang, Shanghai Scientific & Technical Publishers, October, 2014; pp. 320-330.

*DETERMINATION OF TRIAPINE, A RIBONUCLEOTIDE REDUCTASE INHIBITOR, IN HUMAN PLASMA BY LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY (LC-MS/MS).  Ye Feng, Charles A. Kunos, Yan Xu#, Biomedical Chromatography, DOI 10.1002/bmc.3434 (2015).

*DETERMINATION OF TRIAPINE, A RIBONUCLEOTIDE REDUCTASE INHIBITOR, IN HUMAN PLASMA BY LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY (LC-MS/MS).  Ye Feng, Charles A. Kunos, Yan Xu#, Biomedical Chromatography, 29, 1380¿1387 (2015).

*NOVEL PROTEIN DISULFIDE ISOMERASE INHIBITOR WITH ANTI-CANCER ACTIVITY IN MULTIPLE MYELOMA.  Sergei Vatolin, James G. Phillips, Babal K. Jha, Shravya Govindgari, Jennifer Hu, Dale Grabowski, Yvonne Parker, Daniel J. Lindner, Fei Zhong, Clark W. Distelhorst, Mitchell R. Smith, Claudiu Cotta, Yan Xu, Sujatha Chilakala, Rebecca R. Kuang, Samantha Tall, Frederic J. Reu#, Cancer Research, DOI: 10.1158/0008-5472.CAN-15-3099 (2016).

*TARGETING RADIORESISTANT BREAST CANCER CELLS BY SINGLE AGENT CHK1 INHIBITOR VIA ENHANCING REPLICATION STRESS.  Yao Zhang, Jinzhi Lai, Zhanwen Du, Jinnan Gao, Shuming Yang, Shashank Gorityala, Xiahui Xiong, Ou Deng, Zhefu Ma, Chunhong Yan, Gonzalo Susana, Yan Xu, and Junran Zhang#,  Oncotarget,  7, 34688-34702 (2016).

*DETERMINATION OF MLN0128, AN INVESTIGATIONAL ANTINEOPLASTIC AGENT, IN HUMAN PLASMA BY LC-MS/MS.  Sandeep R. Kunati, Yan Xu#, Biomedical Chromatography, DOI: 10.1002/bmc.3818 (2016).

*INHIBITION OF URACIL DNA GLYCOSYLASE SENSITIZES CANCER CELLS TO 5-FLUORODEOXYURIDINE THROUGH REPLICATION FORK COLLAPSE-INDUCED DNA DAMAGE.  Yan Yan, Xiangzi Han, Yulan Qing, Allison G. Condie, Shashank Gorityala, Shuming Yang, Yan Xu, Youwei Zhang, Stanton L. Gerson#, Oncotarget, 7:59299-59313 (2016).

*ONCOGENIC PIK3CA MUTATIONS REPROGRAM GLUTAMINE METABOLISM IN COLORECTAL CANCER.  Yujun Hao, Yardena Samuels, Qingling Li, Dawid Krokowski, Bo-Jhih Guan, Chao Wang, Zhicheng Jin, Bohan Dong, Bo Cao, Xiujing Feng, Min Xiang, Claire Xu, Stephen Fink, Neal Meropoll, Yan Xu, Ronald A. Conlon, Sanford Markowitz, Kenneth W Kinzler, Victor E. Velculescu, Henri Brunengraber, Joseph E. Willis, Thomas LaFramboise, Maria Hatzoglou, Guo-Fang Zhang, Bert Vogelstein, Zhenghe Wang#, Nature Cell Biology, DOI:10.1038/ncomms11971 (2016). Nature Communications, 7, DOI:10.1038/ncomms11971 (2016).

*FUCOSYLATION DEFICIENCY IN MICE LEADS TO COLITIS AND ADENOCARCINOMA.  Yiwei Wang, Dan Huang, Kai-Yuan Chen, Min Cui, Weihuan Wang, Xiaoran Huang, Amad Awadellah, Qing Li, Ann Friedman, William W. Xin, Luca Di Martino, Fabio Cominelli, Alex Miron, Ricky Chan, James G. Fox, Yan Xu, Xiling Shen, Mathew F. Kalady, Sanford Markowitz, Ivan Maillard, John B. Lowe, Wei Xin, Lan Zhou#, Gastroenterology, 152, 193¿205.e10 (2017).

*DETERMINATION OF FATTY ACID METHYL ESTERS DERIVED FROM ALGAE SCENEDESMUS DIMORPHUS BIOMASS BY GC-MS WITH ONE-STEP ESTERIFICATION OF FREE FATTY ACIDS AND TRANSESTERIFICATION OF GLYCEROLIPIDS. Satya Girish Chandra Avula, Joanne Belovich, Yan Xu#, Journal of Separation Science, 40, 2214¿2227 (2017).

*UTILIZATION OF MECHANISTIC ENZYMOLOGY TO EVALUATE THE PHYSIOLOGICAL SIGNIFICANCE OF ADP BINDING TO HUMAN LON PROTEASE.  Jennifer Fishovitz, Zhou Sha, Sujatha Chilakala, Iteen Cheng, Yan Xu, Irene Lee#, Frontiers in Molecular Biosciences, DOI: 10.3389/fmolb.2017.00047 (2017).

*PHASE I CLINICAL TRIAL OF THE BASE EXCISION REPAIR METHOXYAMINE IN COMBINATION WITH FLUDARABINE FOR PATIENTS WITH ADVANCED HEMATOLOGIC MALIGNANCIES. Paolo F. Caimi#, Brenda W. Cooper, Basem M. William, Afshin Dowlati, Paul M. Barr, Brian Hill, Pingfu Fu, John Pink, Yan Xu, Hillard M. Lazarus, Marcos de Lima, Stanton L. Gerson, Oncotarget, 8, 79864-79875 (2017).

*MICROWAVE-ASSISTED ENZYMATIC HYDROLYSIS OF DNA FOR MASS SPECTROMETRIC ANALYSIS: A NEW STRATEGY FOR ACCELERATED HYDROLYSIS.  Sujatha Chilakala, Lan Li, Ye Feng, Yan Xu#, Analytical Biochemistry, 546, 28¿34 (2018).

*DEVELOPMENT AND VALIDATION OF AN LC¿MS/MS METHOD FOR QUANTITATIVE DETERMINATION OF GS87, A NOVEL ANTINEOPLASTIC AGENT, IN MOUSE PLASMA.  Sandeep R. Kunati, Shuming Yang, David Wald, Yan Xu#, Journal of Pharmaceutical and Biomedical Analysis, 153, 145¿151 (2018).

*RNF126 AS A BIOMARKER OF A POOR PROGNOSIS IN INVASIVE BREAST CANCER AND CHEK1 INHIBITOR EFFICACY IN BREAST CANCER CELLS.  Xiaosong Yang, You Pan, Zhaojun Qiu, Zhanwen Du, Yao Zhang, Pengyan Fa, Shashank Gorityala, Shanhuai Ma, Shunqiang Li, Ceshi Chen, Hongbing Wang, Yan Xu, Chunhong Yan, Keri Ruth, Zhefu Ma and Junran Zhang#, Clinical Cancer Research, DOI: 10.1158/1078-0432.CCR-17-2242 (2018).

*AN LC-MS/MS METHOD FOR SIMULTANEOUS DETERMINATION OF CURCUMIN, CURCUMIN GLUCURONIDE AND CURCUMIN SULFATE IN A PHASE II CLINICAL TRIAL.  Sandeep R. Kunati, Shuming Yang, Basem M. William, Yan Xu#, Journal of Pharmaceutical and Biomedical Analysis, 156, 189¿198 (2018).

*SIMULTANEOUS DETERMINATION OF DIHYDROTESTOSTERONE AND ITS METABOLITES IN MOUSE SERA BY LC-MS/MS WITH CHEMICAL DERIVATIZATION.  Shashank Gorityala, Shuming Yang, Monica M. Montano, Yan Xu#, Journal of Chromatography B, 1090, 22-35 (2018).

*A RAPID AND SENSITIVE LC-MS/MS METHOD FOR QUANTITATIVE ANALYSIS OF CARDIOLIPIN (18:2)4 IN HUMAN LEUKOCYTES AND MOUSE SKELETAL  MUSCLES.  Gang Xu, Xiao Liu, Yachun Shu, Jagan A. Pillai, Yan Xu#, Journal of Pharmaceutical and Biomedical Analysis, 158, 386¿394 (2018).

*ANALYSIS OF OXYGEN-18 LABELED PHOSPHATE TO STUDY POSITIONAL ISOTOPE EXPERIMENTS USING LC-QTOF-MS.  Sujatha Chilakala, Iteen Cheng, Ireen Lee, Yan Xu#, Analytical Biochemistry, 566, 62-66 (2019).

*TRACKING DECITABINE INCORPORATION INTO MALIGNANT MYELOID CELL DNA IN VITRO AND IN VIVO BY LC-MS/MS WITH ENZYMATIC DIGESTION.  Sujatha Chilakala, Feng Ye, Lan Li, Dr. Reda Mahfouz, Ebrahem Quteba, Yogen Saunthararajah, Yan Xu#, Scientific Reports, 9:4558 (2019), available at https://doi.org/10.1038/s41598-019-41070-y1.

*AN LC-MS/MS METHOD FOR DETERMINATION OF O6-BENZYLGUANINE AND ITS METABOLITE O6-BENZYL-8-OXOGUANINE IN HUMAN PLASMA.  Chandana Mannem, Yan Xu#, Biomedical Chromatography, 34 (2) (2019), https://doi.org/10.1002/bmc.4750

*UNTARGETED METABOLOMICS PROFILING AND GLOBAL SEMI-QUANTITATION OF A PRESCRIPTION CHINESE HERBAL MEDICINE FORMULA YINQIAOSAN USING UPLC-QTOF-MS WITH A SINGLE EXOGENOUS REFERENCE INTERNAL STANDARD.  Yachun Shu#, Chandana Mannem, Gang Xu, Shashank Gorityala, Xiao Liu, Yan Xu#, Planta Medica International Open, 7:e45-e57 (2020), https://doi.org/10.1055/a-1141-0119.

*A SELECTIVE FLUOROGENIC PEPTIDE SUBSTRATE FOR THE HUMAN MITOCHONDRIAL ATP-DEPENDENT PROTEASE COMPLEX ClpXP.  Zhou Sha, Jennifer Fishovitz¿, Susan Wang, Sujatha Chilakala, Yan Xu, Irene Lee#, ChemBioChem. 21, 1-13 (2020), https://doi.org/10.1002/cbic.202000030.

*A PROTEOLYTIC SITE-DIRECTED AFFINITY LABEL TO INHIBIT THE HUMAN ATP-DEPENDENT PROTEASE CASEINOLYTIC COMPLEX XP.  Zhou Sha, Sujatha Chilakala, George Crabill, Iteen Cheng, Yan Xu, Jennifer Fishovitz#, Irene Lee#, ChemBioChem. 21, 1-12 (2020), https://doi.org/10.1002/cbic.202000031.

*ANTI-HELICOBACTER PYLORI ASSOCIATED GASTRITIS EFFECT OF THE ETHYL ACETATE EXTRACT OF ALPINIA OFFICINARUM HANCE THROUGH MAPK SIGNALING PATHWAY.  Dan Liu#, Xiaoqing Ma, Pengtao You, Yan Xu, Xiaochuan Ye, Yijun Tu, Yanwen Liu, Min Yang, Journal of Ethnopharmacology (2020), https://doi.org/10.1016/j.jep.2020.113100.

*A NEW STRATEGY OF OVERCOMING BOTH MATRIX EFFECT AND SHORTAGE OF REFERENCE STANDARDS FOR DETERMINATION OF MULTI-COMPONENTS IN THE RHIZOMES OF ALPINIA OFFICINARUM HANCE USING UHPLC-MS/MS WITH SINGLE EXOGENOUS INTERNAL STANDARD.  Dan Liu, Gang Xu, Xiaoqing Ma, Yan Xu#, Food Analytical Methods (2020), https://doi.org/10.1007/s12161-020-01802-7.

*5-FLUOROURACIL ENHANCES THE ANTI-TUMOR ACTIVITY OF THE GLUTAMINASE INHIBITOR CB-839 ON PIK3CA-MUTANT COLORECTAL CANCERS.  Zhenghe Wang#, Yiqing Zhao, Xiujing Feng, Yicheng Chen, J Selfridge, Shashank Gorityala, Zhanwen Du, Janet Wang, Yujun Hao, Gino Cioffi, Ronald Conlon, Jill Barnholtz-Sloan, Joel Saltzman, Smitha Krishnamurthi, Shaveta Vinayak, Martina Veigl, Yan Xu, David Bajor, Sanford Markowitz, Neal Meropol, and Jennifer Eads, Cancer Research (2020), DOI: 10.1158/0008-5472.CAN-20-0600.  

*UNRAVELING THE MOLECULAR MECHANISMS OF FRUCTUS ANISI STELLATI AS REMEDY FOR INFANTILE COLIC BY NETWORK PHARMACOLOGY.  Xingyu Li#, Yan Xu#, Evidence-Based Complementary and Alternative Medicine (2020), https://doi.org/10.1155/2020/9210304.

*PHASE I CLINICAL TRIAL OF TEMOZOLOMIDE AND METHOXYAMINE (TRC-102), AN INHIBITOR OF BASE EXCISION REPAIR, IN PATIENTS WITH ADVANCED SOLID TUMORS. Jennifer R. Eads, Smitha S. Krishnamurthi, Joel Saltzman, Joseph A. Bokar, Panos Savvides, Neal J. Meropol, Joseph Gibbons, Henry Koon, Neelesh Sharma, Lisa Rogers, John J. Pink, Yan Xu, Jan H. Beumer, John Riendeau, Stanton L. Gerson, Pingfu Fu, Afshin Dowlati#, Investigational New Drugs, 39, 142¿151 (2021), https://doi.org/10.1007/s10637-020-00962-x.

*COMBINED MASS SPECTROMETRY-GUIDED GENOME MINING AND VIRTUAL SCREENING FOR ACARICIDAL ACTIVE SECONDARY METABOLITES OF BACILLUS VELEZENSIS W1.  Xingyu Li#, Shahzad Munir, Yan Xu, Yue-Hu Wang, Yue-Qiu He#, RSC Adv., 11, 25441-25449 (2021), DOI: 10.1039/d1ra01326b.

*DOWNREGULATION OF DIHYDROTESTOSTERONE AND ESTRADIOL LEVELS BY HEXIM1.  Vikas Sharma, Shashank Gorityala, Yan Xu, and Monica M. Montano¿, Endocrinology 163 (2022), https://doi.org/10.1210/endocr/bqab236.

*NETWORK-BASED PHARMACOLOGY STUDY REVEALS PROTEIN TARGETS FOR MEDICAL BENEFITS AND HARMS OF CANNABINOIDS IN HUMANS.  Xingyu Li, Amit Madhukar Kudke, Felix Joseph Nepveux, and Yan Xu¿, Appl. Sci. 12, 2205 (2022), https://doi.org/10.3390/app12042205.

*METABOLOMICS ANALYSES OF TRADITIONAL CHINESE MEDICINE FORMULA SHUANG HUANG LIAN BY UHPLC-QTOF-MS/MS.  Gang Xu, Yachun Shu, Yan Xu¿, Chinese Medicine 17:62, (2022), https://doi.org/10.1186/s13020-022-00610-x.

*ENHANCED GROWTH OF MICROALGAE AND PRODUCTION OF LIPIDS VIA ELECTROSTATICALLY CONTROLLED PHOTOSYNTHESIS.  Xuyang Shi, Anup S. Mathew, Yan Xu, Siu-Tung Yau¿, Gang Xu, ACS Sustainable Chem. Eng. 10, 11459-11465 (2022), https://pubs.acs.org/doi/10.